Verrica Pharmaceuticals Inc.
NASDAQ:VRCA
1.94 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 5.177 | 3.826 | 1.988 | 2.917 | 0.182 | 0.037 | 0.068 | 8.319 | 0.214 | 0.431 | -12 | 0 | 0 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.542 | 1.138 | 0.381 | 0.145 | 0.136 | 0.068 | 0.062 | 0.196 | 0.163 | 0.158 | 0.2 | 0.111 | 0.094 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 4.635 | 2.688 | 1.608 | 2.772 | 0.046 | -0.031 | 0.006 | 8.123 | 0.051 | 0.273 | -12.2 | -0.111 | -0.094 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.895 | 0.703 | 0.809 | 0.95 | 0.253 | -0.838 | 0.088 | 0.976 | 0.238 | 0.633 | 1.017 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 3.319 | 4.948 | 5.32 | 6.51 | 5.725 | 2.739 | 3.03 | 2.946 | 4.162 | 2.723 | 3.357 | 3.763 | 3.447 | 5.362 | 2.272 | 4.988 | 3.521 | 4.892 | 3.972 | 3.049 | 3.928 | 4.487 | 4.917 | 3.484 | 3.609 | 0.929 | 1.118 | 1.12 | 0.977 | 0.515 |
| General & Administrative Expenses
| 0 | 14.839 | 30.31 | 20.054 | 5.937 | 4.319 | 3.189 | 3.925 | 5.173 | 5.118 | 5.113 | 8.005 | 7.284 | 6.578 | 9.761 | 4.649 | 5.11 | 4.988 | 4.018 | 3.494 | 3.593 | 3.539 | 3.271 | 3.681 | 2.503 | 0.986 | 0.316 | 0.238 | 0.118 | 0.055 |
| Selling & Marketing Expenses
| 0 | 1.5 | -13.315 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 16.522 | 16.339 | 16.887 | 20.054 | 5.937 | 4.319 | 3.189 | 3.925 | 5.173 | 5.118 | 5.113 | 8.005 | 7.284 | 6.578 | 9.761 | 4.649 | 5.11 | 4.988 | 4.018 | 3.494 | 3.593 | 3.539 | 3.271 | 3.681 | 2.503 | 0.986 | 0.316 | 0.238 | 0.118 | 0.055 |
| Other Expenses
| -0.005 | -0.011 | 0.035 | 0.125 | 0 | 0 | -0.006 | 0.005 | -0.001 | 0 | 0 | 0 | 0 | 0 | -0.001 | 0 | 0 | 0 | 0.353 | 0 | -0.003 | 0 | 0 | -0.001 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 19.841 | 21.287 | 22.207 | 26.689 | 11.662 | 7.058 | 6.219 | 6.871 | 9.335 | 7.841 | 8.47 | 11.768 | 10.731 | 11.94 | 12.033 | 9.637 | 8.631 | 9.88 | 7.99 | 6.543 | 7.521 | 8.026 | 8.188 | 7.165 | 6.112 | 1.915 | 1.434 | 1.358 | 1.095 | 0.57 |
| Operating Income
| -15.206 | -18.599 | -20.599 | -23.917 | -11.616 | -7.089 | -6.213 | 1.448 | -9.121 | -7.41 | -8.47 | -11.768 | -10.731 | 0.06 | -12.033 | -9.637 | -8.631 | -9.88 | -7.99 | -6.543 | -7.521 | -8.026 | -8.188 | -7.165 | -6.112 | -1.915 | -1.434 | -1.358 | -1.095 | -0.57 |
| Operating Income Ratio
| -2.937 | -4.861 | -10.362 | -8.199 | -63.824 | -191.595 | -91.368 | 0.174 | -42.621 | -17.193 | 0.706 | 0 | 0 | 0.005 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -1.98 | -1.732 | -4.015 | -0.885 | 0.626 | 0.5 | 0.281 | -1.365 | -1.047 | -1.06 | -1.097 | -1.061 | -1.044 | -0.996 | -0.001 | -0.849 | -0.778 | 0.058 | 0.353 | 0.453 | -0.003 | 0.547 | 0.61 | -0.001 | 0.153 | 0.041 | -0.001 | -0.001 | 0 | 0 |
| Income Before Tax
| -17.186 | -20.331 | -24.614 | -24.802 | -10.99 | -6.589 | -5.932 | 0.083 | -10.168 | -8.47 | -9.54 | -12.829 | -11.775 | -0.936 | -12.977 | -10.486 | -9.409 | -9.822 | -7.637 | -6.09 | -7.001 | -7.479 | -7.578 | -6.739 | -5.959 | -1.874 | -1.435 | -1.359 | -1.095 | -0.57 |
| Income Before Tax Ratio
| -3.32 | -5.314 | -12.381 | -8.503 | -60.385 | -178.081 | -87.235 | 0.01 | -47.514 | -19.652 | 0.795 | 0 | 0 | -0.078 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0.297 | 0.227 | -0.353 | 0.626 | -0.5 | -0.281 | 1.365 | 1.047 | 1.06 | 1.097 | 0.031 | 0.033 | 0.032 | 0.792 | 0.064 | 0.126 | 0.278 | -0.093 | 0 | -0.523 | 0 | 0.6 | -0.001 | -0.003 | -1.888 | -1.434 | -1.358 | -1.095 | -0.57 |
| Net Income
| -17.186 | -20.331 | -24.614 | -24.802 | -10.99 | -6.089 | -5.651 | -1.282 | -11.215 | -9.53 | -9.54 | -12.829 | -11.775 | -0.936 | -12.977 | -10.486 | -9.409 | -9.822 | -7.637 | -6.09 | -7.001 | -7.479 | -7.578 | -6.739 | -5.959 | -1.874 | -1.435 | -1.359 | -1.095 | -0.57 |
| Net Income Ratio
| -3.32 | -5.314 | -12.381 | -8.503 | -60.385 | -164.568 | -83.103 | -0.154 | -52.407 | -22.111 | 0.795 | 0 | 0 | -0.078 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.37 | -0.44 | -0.53 | -0.54 | -0.24 | -0.14 | -0.14 | -0.029 | -0.41 | -0.35 | -0.35 | -0.47 | -0.43 | -0.037 | -0.52 | -0.42 | -0.38 | -0.39 | -0.31 | -0.24 | -0.28 | -0.3 | -0.3 | -0.27 | -1.04 | -0.075 | -0.072 | -0.068 | -0.055 | -0.029 |
| EPS Diluted
| -0.37 | -0.44 | -0.53 | -0.54 | -0.24 | -0.14 | -0.14 | -0.029 | -0.41 | -0.35 | -0.35 | -0.47 | -0.43 | -0.037 | -0.52 | -0.42 | -0.38 | -0.39 | -0.31 | -0.24 | -0.28 | -0.3 | -0.3 | -0.27 | -1.04 | -0.075 | -0.072 | -0.068 | -0.055 | -0.029 |
| EBITDA
| -14.872 | -18.259 | -20.382 | -23.917 | -10.855 | -6.458 | -5.932 | 1.728 | -9.004 | -7.29 | -8.443 | -11.683 | -10.661 | 0.103 | -11.986 | -9.568 | -8.493 | -9.588 | -7.99 | -6.46 | -7.48 | -7.986 | -7.578 | -6.734 | -6.112 | -1.915 | -1.434 | -1.358 | -1.095 | -0.57 |
| EBITDA Ratio
| -2.873 | -4.772 | -10.253 | -8.199 | -59.643 | -174.541 | -87.235 | 0.208 | -42.075 | -16.914 | 0.704 | 0 | 0 | 0.009 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |